# VERTEX PHARMACEUTICA (VRTX) — Q1-2016 Earnings Results

**Report date:** 2016-04-27 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/VRTX/earnings/Q1-2016

## Post-Earnings Brief

### Headline

Vertex Pharmaceuticals Beats on EPS, Stock Up 0.43%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.09 | N/A | +143.24% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No guidance data is available.

### What It Means

Vertex Pharmaceuticals reported better-than-expected earnings per share, which led to a slight increase in the stock price by 0.43%. However, there was no revenue figure provided, and no guidance was offered for future performance. The strong EPS surprise may indicate positive momentum in the company's operations.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/VRTX/earnings/Q1-2016_